Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

NCT02858869 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Neoplasm in the Brain
Metastatic Melanoma
Mucosal Melanoma
Ocular Melanoma
Stage IV Non-Small Cell Lung Cancer
Stage IV Skin Melanoma
Melanoma of Unknown Primary

Interventions

BIOLOGICAL: Pembrolizumab
RADIATION: Stereotactic Radiosurgery

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]